Evidence map›Paper›PMID 26816223›Full record

Observational studyArthritis care & research2016

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.

Kathleen McElhone, Janice Abbott, Chris Sutton, Montana Mullen, Peter Lanyon, Anisur Rahman, Chee-Seng Yee, Mohammed Akil, Ian N Bruce, Yasmeen Ahmad and 2 more

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Arthritis care & research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03426384 (Can Individualized Diet and Lifestyle Modifications Derived From Digital Therapeutics and Health Coaching Improve Symptoms of Systemic Lupus Erythematosus), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03426384 nacompletednot on this mapstarted 2018, after this paper: background citation

Can Individualized Diet and Lifestyle Modifications Derived From Digital Therapeutics and Health Coaching Improve Symptoms of Systemic Lupus Erythematosus

TypeinterventionalSponsorMymee Inc.Ran2018 to 2019Enrolled50ConditionsSystem, Lupus ErythematosusArmsMymee Program
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Exercise as adjunctive therapy for systemic lupus erythematosus.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Lupus nephritis.Nature reviews. Disease primers · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Flares in patients with systemic lupus erythematosus.Rheumatology (Oxford, England) · 2021
    Observational
  13. Article
  14. Article
  15. Review
  16. What is the current evidence of the impact on quality of life whilst waiting for management/treatment of orthopaedic/musculoskeletal complaints? A systematic scoping review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathleen McElhoneRoyal Blackburn Hospital, Blackburn, UK.
Janice AbbottUniversity of Central Lancashire, Preston, UK.
Chris SuttonUniversity of Central Lancashire, Preston, UK.
Montana MullenUniversity of Central Lancashire, Preston, UK.
Peter LanyonQueen's Medical Centre Campus, Nottingham University Hospitals, Nottingham, UK.
Anisur RahmanUniversity College London, London, UK.
Chee-Seng YeeDoncaster Royal Infirmary, Doncaster, UK.
Mohammed AkilRoyal Hallamshire Hospital, Sheffield, UK.
Ian N BruceThe Kellgren Centre for Rheumatology, National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals National Health Service Foundation Trust and Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Yasmeen AhmadPeter Maddison Rheumatology Centre, Betsi Cadwaladr University Health Board, Llandudno Hospital, Llandudno, UK.
Caroline GordonUniversity of Birmingham, National Institute for Health Research Wellcome Trust Clinical Research Facility, University Hospital Birmingham National Health Service Foundation Trust, and West Birmingham Hospitals National Health Service Trust, Birmingham, UK.
Lee-Suan TehRoyal Blackburn Hospital, Blackburn, UK. lsteh@btinternet.com.

Funding

Arthritis Research UK 19230Versus Arthritis 19230Wellcome Trust
6 · The paper itself

Abstract

objectiveAs a health-related quality of life (HRQOL) measure, the LupusQoL is a reliable and valid measure for adults with systemic lupus erythematosus (SLE). This study evaluates the responsiveness and minimal important differences (MIDs) for the 8 LupusQoL domains.

methodsPatients experiencing a flare were recruited from 9 UK centers. At each of the 10 monthly visits, HRQOL (LupusQoL, Short Form 36 health survey [SF-36]), global rating of change (GRC), and disease activity using the British Isles Lupus Assessment Group 2004 index were assessed. The responsiveness of the LupusQoL and the SF-36 was evaluated primarily when patients reported an improvement or deterioration on the GRC scale and additionally with changes in physician-reported disease activity. MIDs were estimated as mean changes when minimal change was reported on the GRC scale.

resultsA total of 101 patients were recruited. For all LupusQoL domains, mean HRQOL worsened when patients reported deterioration and improved when patients reported an improvement in GRC; SF-36 domains showed comparable responsiveness. Improvement in some domains of the LupusQoL/SF-36 was observed with a decrease in disease activity, but when disease activity worsened, there was no significant change. LupusQoL MID estimates for deterioration ranged from -2.4 to -8.7, and for improvement from 3.5 to 7.3; for the SF-36, the same MID estimates were -2.0 to -11.1 and 2.8 to 10.9, respectively.

conclusionAll LupusQoL domains are sensitive to change with patient-reported deterioration or improvement in health status. For disease activity, some LupusQoL domains showed responsiveness when there was improvement but none for deterioration. LupusQoL items were derived from SLE patients and provide the advantage of disease-specific domains, important to the patients, not captured by the SF-36.

Indexed as

Disease ProgressionHealth StatusQuality of LifeAdultFemaleHealth SurveysHumansLongitudinal StudiesLupus Erythematosus, SystemicMaleMiddle AgedProspective StudiesPsychometricsSensitivity and SpecificitySeverity of Illness IndexUnited Kingdom

Identifiers

PMID26816223
PMCPMC5053261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.